v3.26.1
Segment reporting (Details 4)
₨ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2026
INR (₨)
Mar. 31, 2026
USD ($)
Mar. 31, 2025
INR (₨)
Mar. 31, 2024
INR (₨)
Disclosures Of Geographical Areas [Line Items]        
Revenues ₨ 335,933 [1] $ 3,580 ₨ 325,535 [1] ₨ 279,164 [1]
United States [Member]        
Disclosures Of Geographical Areas [Line Items]        
Revenues 117,892   149,351 135,565
India [Member]        
Disclosures Of Geographical Areas [Line Items]        
Revenues 64,537   55,830 48,473
Russia [Member]        
Disclosures Of Geographical Areas [Line Items]        
Revenues 34,786   25,958 22,301
Others [Member]        
Disclosures Of Geographical Areas [Line Items]        
Revenues [2] ₨ 118,718   ₨ 94,396 ₨ 72,825
[1] Revenues for the year ended March 31, 2026 do not include inter-segment revenues from the PSAI segment to the Global Generics segment, of Rs.7,270 (as compared to Rs.9,389 and Rs.10,707 for the years ended March 31, 2025 and 2024, respectively) and from the PSAI segment to the Others segment of Rs.0 (as compared to Rs.0 and Rs.72 for the years ended March 31, 2025 and 2024, respectively)
[2] Others include Germany, the United Kingdom, Ukraine, Romania, Brazil and other countries across the world.